Health Condition 1: I219- Acute myocardial infarction, unspecified
Conditions
Interventions
Intervention1: Patient and Clinician "Cholesterol Score Card": This passport-sized
document will serve as a communication, engagement and
activation tool for patients. It will be provided to participa
Sponsors
Monash University
Eligibility
Inclusion criteria
Inclusion criteria: Patients hospitalised with Type I Myocardial Infarction aged equal to or more than 18 years of age.
Exclusion criteria
Exclusion criteria: LDL Cholesterol more than 1.4 mmol per litre at baseline. unable to provide contact details of a nominated clinician. Unable to provide written informed consent. Unlikely to survive greater than 12 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proportion of patients achieving LDL-Cholesterol less than 1.4 mmol/l at six monthsTimepoint: The primary outcome will be measured at 6 months from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| the proportion of patients who undergo intensification of lipid-lowering therapy at 6 months. The proportion of patients prescribed a guideline- recommended high-intensity statin at any time during the first 6 months. The proportion of patients prescribed a guideline- recommended high-intensity statin at 6 months.increase the proportion of patients reporting high levels of adherence to their lipid lowering therapy at 6 months The level of patient activation & engagement in their care.Timepoint: Intensification of Lipid-Lowering Therapy: At 6 months. Prescription of Guideline-Recommended High-Intensity Statin: At any time during the first 6 months & at 6 months. High Adherence to Lipid-Lowering Therapy: At 6 months. Patient Activation & Engagement (PAM-13): At baseline & 6 months. | — |
Countries
Australia, China, India, Japan, Malaysia, Republic of Korea, Singapore, Taiwan, Thailand
Contacts
Public ContactRagini Singh
All India Institute of Medical Sciences, Rajkot
Outcome results
None listed